Open Access
Publication ahead of print
Journal
Med Buccale Chir Buccale
Section Cas clinique et revue de la littérature / Up-to date review and case report
DOI https://doi.org/10.1051/mbcb/2016051
Published online 01 February 2017
  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69(3):412-422. [CrossRef] [PubMed]
  2. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Borenstein A. Vascular anomalies classifcation : recommendations from the international society for the study of vascular anomalies. Pediatrics 2015;136(1):e203-214. [CrossRef] [PubMed]
  3. Ernemann U, Kramer U, Miller S, Bisdas S, Rebmann H, Breuninger H, et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010;75(1):2-11. [CrossRef] [PubMed]
  4. Mulligan PR, Prajapati HJS, Martin LG, Patel TH. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 2014;87(1035):20130392. [CrossRef] [PubMed]
  5. Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region--a review. Br J Oral Maxillofac Surg 2006;44(4):263-272. [CrossRef] [PubMed]
  6. Bonet-Coloma C, Minguez-Martinez I, Aloy-Prosper A, Rubio-Serrana M, Penarrocha-Diago MA, Penarrocha-Diago M. Clinical characteristics, treatment and evolution in 14 cases of pediatric orofacial lymphangioma. J Oral Maxillofac Surg 2011;69:e96-99. [CrossRef] [PubMed]
  7. Brennan TD, Miller AS, Chen SY. Lymphangiomas of the oral cavity: a clinicopathologic, immunohistochemical, and electron-microscopic study. J Oral Maxillofac Surg 1997;55(9):932-935. [CrossRef] [PubMed]
  8. Nosher JL. Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment. World J Radiol 2014;6(9):677. [CrossRef] [PubMed]
  9. Zachariades N, Koundouris I. Lymphangioma of the oral cavity: report of a case. J Oral Med 1984;39(1):33-34. [PubMed]
  10. Wiegand S, Eivazi B, Barth PJ, von Rautenfeld DB, Folz BJ, Mandic R, et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453(1):1-8. [CrossRef] [PubMed]
  11. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular. Development 1996; 122(12):3829-3837. [PubMed]
  12. Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg 2012;147(4):627-639. [CrossRef]
  13. Riché MC. [Lymphangioma]. Rev Prat 1992;42(16):2041-2043. [PubMed]
  14. Enjolras O, Herbreteau D, Lemarchand F, Riche MC, Laurian C, Brette MD, et al. [Hemangiomas and superficial vascular malformations: classification]. J Mal Vasc 1992;17(1):2-19. [PubMed]
  15. Segado Arenas A, Flores González J-C, Rubio Quiñones F, Quintero Otero S, Hernández González A, Pantoja Rosso S. Obstruction iatrogène sévère de la voie aérienne par un lymphangiome lingual. Arch Pédiatrie 2011;18(9):983-986. [CrossRef]
  16. Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 2011;47(12):1105-1109. [CrossRef] [PubMed]
  17. Turner C, Gross S. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. Am J Pediatr Hematol Oncol 1994;16(4):325-328. [PubMed]
  18. Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol 2013; 77(9):1589-1592. [CrossRef]
  19. Pierrot S, Manach Y, Couloigner V. Lymphangiomes cervicofaciaux : imagerie, diagnostic et traitement. EMC - Oto-Rhino-Laryngol 2011;6(2):1-7. [CrossRef]
  20. Moser T, Chapot R, Jahn C, Salvador D, Baldi S, Beaujeux R. Imagerie des anomalies vasculaires des tissus mous : diagnostic et traitement. Feuill Radiol 2008;45(1):13-36. [CrossRef]
  21. Katsoulas N, Tosios KI, Argyris P, Koutlas IG, Sklavounou A. Lymphangioma circumscriptum, angiokeratoma, or superficial vascular ectasia with epithelial hyperplasia? Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118(2):e53-57. [CrossRef] [PubMed]
  22. Lavie A, Desouches C, Casanova D, Bardot J, Magalon G. Traitement chirurgical des malformations lymphatiques. Ann Chir Plast Esthét 2006;51(4-5):433-439. [CrossRef]
  23. Chakravarti A, Bhargava R. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin. Int J Pediatr Otorhinolaryngol 2013;77(8):1367-1369. [CrossRef]
  24. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 2008;138(4):418-424. [CrossRef]
  25. Colbert SD, Seager L, Haider F, Evans BT, Anand R, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013;51(2):98-102. [CrossRef] [PubMed]
  26. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005;69(1):75-80. [CrossRef]
  27. Won JH, Kim BM, Kim C-H, Park SW, Kim MD. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol 2004;15(6):595-600. [CrossRef] [PubMed]
  28. Churchill P, Otal D, Pemberton J, Ali A, Flageole H, Walton JM. Sclerotherapy for lymphatic malformations in children: a scoping review. J Pediatr Surg 2011;46(5):912-922. [CrossRef] [PubMed]
  29. Cable BB, Mair EA. Radiofrequency ablation of lymphangiomatous macroglossia. Laryngoscope 2001;111(10):1859-1861. [CrossRef] [PubMed]
  30. Leboulanger N, Roger G, Caze A, Enjolras O, Denoyelle F, Garabedian EN. Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma. Int J Pediatr Otorhinolaryngol 2008; 72(7):953-958. [CrossRef]
  31. Reinhardt MA, Nelson SC, Sencer SF, Bostrom BC, Kurachek SC, Nesbit ME. Treatment of childhood lymphangiomas with interferon-alpha. J Pediatr Hematol Oncol 1997;19(3):232-236. [CrossRef] [PubMed]
  32. Timke C, Krause MF, Oppermann H-C, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 2007;48(1):108-111. [CrossRef] [PubMed]
  33. Savas JA, Ledon J, Franca K, Chacon A, Zaiac M, Nouri K. Carbon dioxide laser for the treatment of microcystic lymphatic malformations (lymphangioma circumscriptum): a systematic review. Dermatol Surg 2013;39(8):1147-1157. [CrossRef] [PubMed]
  34. Sasaki R, Negishi K, Akita H, Suzuki K, Matsunaga K. Successful treatment of congenital lymphangioma circumscriptum of the vulva with CO2 and long-pulsed Nd:YAG Lasers. Case Rep Dermatol 2014;6(1):1-4. [CrossRef] [PubMed]
  35. Ozeki M, Fukao T, Kondo N. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med 2011;364(14):1380-1382. [CrossRef] [PubMed]
  36. Leboulanger N. Propranolol therapy for hemorrhagic lymphangioma of the tongue. Arch Otolaryngol Neck Surg 2011;137(8):813. [CrossRef]
  37. Maruani A, Brown S, Lorette G, Pondaven-Letourmy S, Herbreteau D, Eisenbaum A. Lack of effect of propranolol in the treatment of lymphangioma in two children. Pediatr Dermatol 2013;30(3):383-385. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.